| Appalachian Hospice Care 1414 South Mayo Trail, Pikeville, KY, 41502 | |
| (606) 432-2112 |
News Archive
A treatment billed as a potential breakthrough in the fight against disease, including cancer, could back-fire and make the disease fitter and more damaging, new research has found.
Healthy stem cells work to restore or repair the body's tissues, but cancer stem cells have a more nefarious mission: to spawn malignant tumors. Cancer stem cells were discovered a decade ago, but their origins and identity remain largely unknown.
Madison Dearborn Partners announced today that it has signed a definitive agreement under which it will acquire a majority ownership position in Ikaria, Inc., a leading provider of proprietary and innovative therapies for the critical care units in hospitals.
The pharmaceutical industry finds itself facing a rapidly changing future in light of the health care bill and the evolving pharmaceutical marketplace. There's never been a time when demand has been so intense for the most accurate and up-to-date information about the pharmaceutical industry, especially pharmaceutical competitive intelligence.
› Verified 4 days ago
| Name | Appalachian Hospice Care |
|---|---|
| Location | 1414 South Mayo Trail, Pikeville, Kentucky |
| Hospice ID | 181524 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| SSA county code | 970 |
News Archive
A treatment billed as a potential breakthrough in the fight against disease, including cancer, could back-fire and make the disease fitter and more damaging, new research has found.
Healthy stem cells work to restore or repair the body's tissues, but cancer stem cells have a more nefarious mission: to spawn malignant tumors. Cancer stem cells were discovered a decade ago, but their origins and identity remain largely unknown.
Madison Dearborn Partners announced today that it has signed a definitive agreement under which it will acquire a majority ownership position in Ikaria, Inc., a leading provider of proprietary and innovative therapies for the critical care units in hospitals.
The pharmaceutical industry finds itself facing a rapidly changing future in light of the health care bill and the evolving pharmaceutical marketplace. There's never been a time when demand has been so intense for the most accurate and up-to-date information about the pharmaceutical industry, especially pharmaceutical competitive intelligence.
› Verified 4 days ago
| NPI Number | 1518927334 |
| Organization Name | Appalachian Hospice Care, Inc. |
| Address | 1414 S Mayo Trl Pikeville, Kentucky, 41501 |
| Phone Number | (606)432-2112 |
News Archive
A treatment billed as a potential breakthrough in the fight against disease, including cancer, could back-fire and make the disease fitter and more damaging, new research has found.
Healthy stem cells work to restore or repair the body's tissues, but cancer stem cells have a more nefarious mission: to spawn malignant tumors. Cancer stem cells were discovered a decade ago, but their origins and identity remain largely unknown.
Madison Dearborn Partners announced today that it has signed a definitive agreement under which it will acquire a majority ownership position in Ikaria, Inc., a leading provider of proprietary and innovative therapies for the critical care units in hospitals.
The pharmaceutical industry finds itself facing a rapidly changing future in light of the health care bill and the evolving pharmaceutical marketplace. There's never been a time when demand has been so intense for the most accurate and up-to-date information about the pharmaceutical industry, especially pharmaceutical competitive intelligence.
› Verified 4 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 94.1 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.1 | 97.3 |
| Patients who got timely treatment for shortness of breath | 98.4 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
A treatment billed as a potential breakthrough in the fight against disease, including cancer, could back-fire and make the disease fitter and more damaging, new research has found.
Healthy stem cells work to restore or repair the body's tissues, but cancer stem cells have a more nefarious mission: to spawn malignant tumors. Cancer stem cells were discovered a decade ago, but their origins and identity remain largely unknown.
Madison Dearborn Partners announced today that it has signed a definitive agreement under which it will acquire a majority ownership position in Ikaria, Inc., a leading provider of proprietary and innovative therapies for the critical care units in hospitals.
The pharmaceutical industry finds itself facing a rapidly changing future in light of the health care bill and the evolving pharmaceutical marketplace. There's never been a time when demand has been so intense for the most accurate and up-to-date information about the pharmaceutical industry, especially pharmaceutical competitive intelligence.
› Verified 4 days ago
| Home Health Aides | 5 |
| Counselors | 2 |
| Homemakers | 2 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 2 |
| Physicians | 1 |
| Registered Nurses | 7 |
| Other Personnel | 2 |
| Total Employees | 23 |
|---|
News Archive
A treatment billed as a potential breakthrough in the fight against disease, including cancer, could back-fire and make the disease fitter and more damaging, new research has found.
Healthy stem cells work to restore or repair the body's tissues, but cancer stem cells have a more nefarious mission: to spawn malignant tumors. Cancer stem cells were discovered a decade ago, but their origins and identity remain largely unknown.
Madison Dearborn Partners announced today that it has signed a definitive agreement under which it will acquire a majority ownership position in Ikaria, Inc., a leading provider of proprietary and innovative therapies for the critical care units in hospitals.
The pharmaceutical industry finds itself facing a rapidly changing future in light of the health care bill and the evolving pharmaceutical marketplace. There's never been a time when demand has been so intense for the most accurate and up-to-date information about the pharmaceutical industry, especially pharmaceutical competitive intelligence.
› Verified 4 days ago
| Counselors | 1 |
| Physicians | 0.5 |
| Total Volunteers | 1.5 |
|---|
News Archive
A treatment billed as a potential breakthrough in the fight against disease, including cancer, could back-fire and make the disease fitter and more damaging, new research has found.
Healthy stem cells work to restore or repair the body's tissues, but cancer stem cells have a more nefarious mission: to spawn malignant tumors. Cancer stem cells were discovered a decade ago, but their origins and identity remain largely unknown.
Madison Dearborn Partners announced today that it has signed a definitive agreement under which it will acquire a majority ownership position in Ikaria, Inc., a leading provider of proprietary and innovative therapies for the critical care units in hospitals.
The pharmaceutical industry finds itself facing a rapidly changing future in light of the health care bill and the evolving pharmaceutical marketplace. There's never been a time when demand has been so intense for the most accurate and up-to-date information about the pharmaceutical industry, especially pharmaceutical competitive intelligence.
› Verified 4 days ago
| Appalachian Hospice Care Location: 1414 South Mayo Trail, Pikeville, Kentucky, 41502 Phone: (606) 432-2112 |